Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5)

被引:25
|
作者
Palte, Rachel L. [1 ]
Schneider, Sebastian E. [1 ]
Altman, Michael D. [1 ]
Hayes, Robert P. [2 ]
Kawamura, Shuhei [1 ]
Lacey, Brian M. [1 ]
Mansueto, My Sam [1 ]
Reutershan, Michael [1 ]
Siliphaivanh, Phieng [1 ]
Sondey, Christopher [1 ]
Xu, Haiyan [1 ]
Xu, Zangwei [1 ]
Ye, Yingchun [1 ]
Machacek, Michelle R. [1 ]
机构
[1] Merck & Co Inc, Computat & Struct Chem, Boston, MA 02115 USA
[2] Computat & Struct Chem, West Point, PA 19486 USA
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2020年 / 11卷 / 09期
关键词
PRMT5; allosteric inhibition; methyltransferase; peptide competitive; SAM competitive; crystal structure; SELECTIVE INHIBITOR; METHYLATION; POTENT; DISCOVERY; DELETION; HISTONE;
D O I
10.1021/acsmedchemlett.9b00525
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Protein arginine methyltransferase 5 (PRMT5) belongs to a family of enzymes that regulate the posttranslational modification of histones and other proteins via methylation of arginine. Methylation of histones is linked to an increase in transcription and regulates a manifold of functions such as signal transduction and transcriptional regulation. PRMT5 has been shown to be upregulated in the tumor environment of several cancer types, and the inhibition of PRMT5 activity was identified as a potential way to reduce tumor growth. Previously, four different modes of PRMT5 inhibition were known-competing (covalently or non-covalently) with the essential cofactor Sadenosyl methionine (SAM), blocking the substrate binding pocket, or blocking both simultaneously. Herein we describe an unprecedented conformation of PRMT5 in which the formation of an allosteric binding pocket abrogates the enzyme's canonical binding site and present the discovery of potent small molecule allosteric PRMT5 inhibitors.
引用
收藏
页码:1688 / 1693
页数:6
相关论文
共 50 条
  • [1] Nucleoside protein arginine methyltransferase 5 (PRMT5) inhibitors
    Lin, Hong
    Luengo, Juan, I
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (11) : 1264 - 1269
  • [2] Protein Arginine Methyltransferase 5 (PRMT5) Mutations in Cancer Cells
    Rasheed, Shayaan
    Bouley, Renee A.
    Yoder, Ryan J.
    Petreaca, Ruben C.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [3] Discovery of Potent and Selective Covalent Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors
    Lin, Hong
    Wang, Min
    Zhang, Yang W.
    Tong, Shuilong
    Leal, Raul A.
    Shetty, Rupa
    Vaddi, Kris
    Luengo, Juan I.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (07): : 1033 - 1038
  • [4] Discovery of First-in-Class Protein Arginine Methyltransferase 5 (PRMT5) Degraders
    Shen, Yudao
    Gao, Guozhen
    Yu, Xufen
    Kim, Huensuk
    Wang, Li
    Xie, Ling
    Schwarz, Megan
    Chen, Xian
    Guccione, Ernesto
    Liu, Jing
    Bedford, Mark T.
    Jin, Jian
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (17) : 9977 - 9989
  • [5] Protein Arginine Methyltransferase 5 (PRMT5) as an Anticancer Target and Its Inhibitor Discovery
    Wang, Yuanxiang
    Hu, Wenhao
    Yuan, Yanqiu
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (21) : 9429 - 9441
  • [6] Protein arginine methyltransferase 5 (PRMT5) is a novel negative regulator of keratinocyte differentiation
    Kanade, S. R.
    Eckert, R. L.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S60 - S60
  • [7] Novel inhibitors of protein arginine methyltransferase 5 (PRMT5) for the treatment of solid tumors
    Chikkanna, Dinesh
    Panigrahi, Sunil Kumar
    Rajagopalan, Sujatha
    Sammeta, Srinivasa Raju
    Lakshminarasimhan, Anirudha
    Mohan, R.
    Narasihmarao, K.
    Chawla, Darshan
    Bhat, Harsha
    Kasturi, Venkateswarlu
    Samiulla, D. S.
    Prasanna, Angelene
    Aithal, Kiran
    Chand, Priyabrata Chand
    Kumar, Naveen
    Marri, Sai Sudheer
    Ganipisetty, Srinivasa Rao
    Rao, Kasieswara N.
    Mutyala, Raju
    Neerukattu, Nageswara Rao
    Nithesh, K.
    Amin, Ramya
    Gorade, Priyanka Machhindra
    Antony, Thomas
    Daginakatte, Girish
    Chelur, Shekar
    Pandit, Chetan
    Samajdar, Susanta
    Ramachandra, Murali
    [J]. MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [8] Protein arginine methyltransferase 5 (PRMT5) is a novel coactivator of constitutive androstane receptor (CAR)
    Kanno, Yuichiro
    Inajima, Jun
    Kato, Sayaka
    Matsumoto, Maika
    Tokumoto, Chikako
    Kure, Yuki
    Inouye, Yoshio
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 459 (01) : 143 - 147
  • [9] Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells
    Mongiardi, Maria Patrizia
    Savino, Mauro
    Bartoli, Laura
    Beji, Sara
    Nanni, Simona
    Scagnoli, Fiorella
    Falchetti, Maria Laura
    Favia, Annarita
    Farsetti, Antonella
    Levi, Andrea
    Nasi, Sergio
    Illi, Barbara
    [J]. SCIENTIFIC REPORTS, 2015, 5
  • [10] Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells
    Maria Patrizia Mongiardi
    Mauro Savino
    Laura Bartoli
    Sara Beji
    Simona Nanni
    Fiorella Scagnoli
    Maria Laura Falchetti
    Annarita Favia
    Antonella Farsetti
    Andrea Levi
    Sergio Nasi
    Barbara Illi
    [J]. Scientific Reports, 5